共 50 条
Anesthetic management of cesarean section in cases of placenta accreta, with versus without abdominal aortic balloon occlusion: study protocol for a randomized controlled trial
被引:6
|作者:
Chu, Qinjun
[1
]
Shen, Dan
[1
]
He, Long
[1
]
Wang, Hongwei
[1
]
Zhao, Xianlan
[2
]
Chen, Zhimin
[2
]
Wang, Yanli
[3
]
Zhang, Wei
[1
]
机构:
[1] Zhengzhou Univ, Dept Anesthesiol, Affiliated Hosp 1, Jian She Dong Lu 1, Zhengzhou 450052, Henan Province, Peoples R China
[2] Zhengzhou Univ, Dept Obstet, Affiliated Hosp 1, Jian She Dong Lu 1, Zhengzhou 450052, Henan Province, Peoples R China
[3] Zhengzhou Univ, Dept Intervent Radiol, Affiliated Hosp 1, Jian She Dong Lu 1, Zhengzhou 450052, Henan Province, Peoples R China
来源:
TRIALS
|
2017年
/
18卷
关键词:
Placenta accreta;
Cesarean section;
Massive hemorrhage;
Abdominal aortic balloon occlusion;
Randomized controlled trial;
SEVERE POSTPARTUM HEMORRHAGE;
UTERINE ARTERY EMBOLIZATION;
INTERNAL ILIAC ARTERIES;
MASSIVE HEMORRHAGE;
PREVIA ACCRETA;
PERCRETA;
HYSTERECTOMY;
FLUOROSCOPY;
PREGNANCIES;
CATHETER;
D O I:
10.1186/s13063-017-1977-5
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
Background: Placenta accreta (PA), a severe complication during delivery, is closely linked with massive hemorrhage which could endanger the lives of both mother and baby. Moreover, the incidence of PA has increased dramatically with the increasing rate of cesarean deliveries in the past few decades. Therefore, studies evaluating the effects of different perioperative managements based on different modalities in the treatment of PA are necessary. Among the numerous treatment measures, prophylactic abdominal aortic balloon occlusion (AABO) in combination with cesarean section for PA seems to be more advantageous than others. However, up to now, all studies on AABO were almost retrospective. Current evidence is insufficient to recommend for or against routinely using the AABO technology for control intraoperative hemorrhage in patients with PA. Thus, we hope to carry out a prospective, randomized controlled trial (RCT) study to confirm the effectiveness of the AABO technology in patients with PA. Methods/design: This trial is an investigator-initiated, prospective RCT that will test the superiority of AABO in combination with cesarean section compared to the traditional hysterectomy following cesarean section for parturients with PA. A total of 170 parturients with PA undergoing cesarean section will be randomized to receive either AABO in combination with cesarean section or the traditional hysterectomy following cesarean section. The primary outcome is estimated blood loss. The most important secondary outcome is the occurrence of cesarean hysterectomy during delivery; others include blood transfusion volume, operating time, neonate's Apgar scores (collected at 1, 5 and 10 min), length of stay in intensive care unit, total hospital stay, and balloon occlusion-relative data. Discussion: This prospective trial will test the superiority of AABO in combination with cesarean section compared to the traditional hysterectomy following cesarean section for parturients with PA. It may provide strong evidence about the benefits and risks of AABO in combination with cesarean section for parturients with PA.
引用
收藏
页数:7
相关论文